Carola Di Frischia

Dr. Carola Di Frischia

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2025 in Reports
Verified
Journal Article
Open access
PDF file
CFCarola Di Frischia
Carola Di Frischia
Marco TallaricoMarco Tallarico
Marco Tallarico
MGMarco Gargari
Marco Gargari
EMEdoardo Magnifico
Edoardo Magnifico
FCFrancesco Cecchetti
Francesco Cecchetti
FCFrancesco Mattia Ceruso
Francesco Mattia Ceruso
Background and Clinical Significance: Maxillary sinus augmentation is a well-established surgical procedure for dental implant placement in the posterior maxilla when the residual alveolar bone height is insufficient. Traditionally, the lateral approach has been preferred in cases with less than 4 mm of bone; however, the crestal approach has emerged as a less invasive alternative, particularly with the advent of advanced techniques and tools such as hydraulic pressure systems and dedicated osteotomy kits. Case Presentation: This case report presents the clinical management of a 68-year-old female patient requiring rehabilitation of the right maxillary molars, where the residual bone height measured only 3.6 mm (in position 1.6) and 2.5 mm (in position 1.7). Using the CAS kit system with rounded drills and hydraulic pressure, a controlled crestal sinus elevation was performed, followed by simultaneous implant placement. Despite the extremely limited bone height, a final insertion torque of 30 Ncm was achieved for both implants, likely due to favorable sinus floor anatomy, under-preparation of the implant sites, and the use of tapered, macro-textured implants. Postoperative follow-up over three years showed stable bone levels and successful prosthetic rehabilitation with single crowns. Conclusions: This case report highlights the potential of the crestal approach in anatomically challenging scenarios. Proper planning, technique, and implant selection are mandatory to achieve predictable and long-lasting outcomes, even in cases previously considered contraindicated for this method. Further randomized controlled trials are needed to confirm this preliminary result.

5 November 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
FCFrancesco Mattia Ceruso
Francesco Mattia Ceruso
FPFrancesco Pernice
Francesco Pernice
MGMarco Gargari
Marco Gargari
CFCarola Di Frischia
Carola Di Frischia
AMAlessandro Mastroianni
Alessandro Mastroianni
EXErta Xhanari
Erta Xhanari
Background/Objectives: Maxillary sinus floor elevation is a well-established procedure for enabling implant placement in the posterior maxilla when residual bone height is insufficient. Minimally invasive transcrestal techniques, including the use of the Crestal Approach Sinus (CAS) kit, have been developed to reduce surgical morbidity while maintaining predictable clinical outcomes. The aim of this retrospective comparative study was to evaluate the clinical and radiographic outcomes of transcrestal sinus floor elevation performed using the CAS kit in patients presenting with residual bone height below or above 4 mm. Methods: Forty-five partially edentulous patients who received single implant-supported rehabilitations in the posterior maxilla between September 2021 and October 2024 were included. Patients were allocated to a test group (residual bone height < 4 mm; n = 20) and a control group (residual bone height ≥ 4 mm; n = 25). All procedures were performed using a standardized CAS-kit protocol with hydraulic membrane elevation and xenogeneic bone grafting. The primary outcomes were implant and prosthetic survival rates and the occurrence of biological or technical complications. Secondary outcomes included the radiographic evaluation of residual bone height, final bone height, vertical bone gain, and bone height above the implant apex at implant placement, prosthetic delivery (9 months) and at the 2 years follow-up. Results: No implant or prosthetic failures and no biological or technical complications were recorded, resulting in 100% implant and prosthetic survival rates. Residual bone height was significantly lower in the test group (2.8 ± 0.8 mm) than in the control group (5.3 ± 1.0 mm) (p < 0.001). Despite significantly greater vertical bone gain in the test group (10.9 ± 1.6 mm vs. 8.2 ± 0.6 mm; p < 0.001), comparable final bone heights were observed immediately after augmentation (13.7 ± 1.7 mm vs. 13.5 ± 1.5 mm; p = 0.742) and at prosthetic delivery (12.6 ± 1.6 mm vs. 12.9 ± 1.6 mm; p = 0.556). Bone height above the implant apex was also similar between the groups at both time points. A modest but statistically significant reduction in augmented bone height was observed during healing in both groups. Conclusions: Within the limitations of this retrospective study, transcrestal sinus floor elevation using the hydraulic CAS-kit technique showed favorable clinical and radiographic outcomes in both groups, including sites with residual bone height below 4 mm. These preliminary findings suggest that the crestal approach may represent a treatment option in carefully selected patients with limited residual bone height. However, larger prospective controlled studies with standardized radiographic assessments and longer follow-up periods are needed to confirm these findings.